223 related articles for article (PubMed ID: 35721724)
1. Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study.
Zhao L; Meng X; Mei Q; Fan H; Liu Y; Zhou X; Zhu H; Zhang S
Front Endocrinol (Lausanne); 2022; 13():877341. PubMed ID: 35721724
[TBL] [Abstract][Full Text] [Related]
2. Acute cardiac complications and subclinical myocardial injuries associated with pheochromocytoma and paraganglioma.
Zhou J; Xuan H; Miao Y; Hu J; Dai Y
BMC Cardiovasc Disord; 2021 Apr; 21(1):203. PubMed ID: 33882857
[TBL] [Abstract][Full Text] [Related]
3. Rates of Pheochromocytoma/Paraganglioma Screening in At-Risk Populations.
Grigoryan S; Nhan W; Zhang L; Urban C; Zhao L; Turcu AF
J Clin Endocrinol Metab; 2023 May; 108(6):e343-e349. PubMed ID: 36469797
[TBL] [Abstract][Full Text] [Related]
4. Seizures in patients with a phaeochromocytoma/paraganglioma (PPGL): A review of clinical cases and postulated pathological mechanisms.
Li Y; Zhang B
Rev Neurol (Paris); 2019 Oct; 175(9):495-505. PubMed ID: 31133278
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Clinical Presentation of Pheochromocytoma and Sympathetic Paraganglioma: A Population-based Study.
Ebbehoj A; Stochholm K; Jacobsen SF; Trolle C; Jepsen P; Robaczyk MG; Rasmussen ÅK; Feldt-Rasmussen U; Thomsen RW; Søndergaard E; Poulsen PL
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2251-e2261. PubMed ID: 33479747
[TBL] [Abstract][Full Text] [Related]
6. TAKOTSUBO-LIKE CARDIOMYOPATHY IN A LARGE COHORT OF PATIENTS WITH PHEOCHROMOCYTOMA AND PARAGANGLIOMA.
Gagnon N; Mansour S; Bitton Y; Bourdeau I
Endocr Pract; 2017 Oct; 23(10):1178-1192. PubMed ID: 28704094
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome.
Y-Hassan S; Falhammar H
Endocrine; 2019 Sep; 65(3):483-493. PubMed ID: 31399912
[TBL] [Abstract][Full Text] [Related]
8. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma.
Gruber LM; Jasim S; Ducharme-Smith A; Weingarten T; Young WF; Bancos I
J Clin Endocrinol Metab; 2021 May; 106(6):e2393-e2401. PubMed ID: 33693908
[TBL] [Abstract][Full Text] [Related]
9. Clinical differences between small and large pheochromocytomas and paragangliomas.
Zhao L; Li Z; Meng X; Fan H; Zhang Z; Zhang Z; Liu Y; Zhou X; Zhu H
Front Endocrinol (Lausanne); 2023; 14():1087506. PubMed ID: 36967797
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas.
Al-Harthy M; Al-Harthy S; Al-Otieschan A; Velagapudi S; Alzahrani AS
Endocr Pract; 2009 Apr; 15(3):194-202. PubMed ID: 19364686
[TBL] [Abstract][Full Text] [Related]
11. Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma.
Giavarini A; Chedid A; Bobrie G; Plouin PF; Hagège A; Amar L
Heart; 2013 Oct; 99(19):1438-44. PubMed ID: 23837998
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Disease in Patients With Sporadic Pheochromocytoma and Paraganglioma.
Li M; Prodanov T; Meuter L; Kerstens MN; Bechmann N; Prejbisz A; Remde H; Timmers HJLM; Nölting S; Talvacchio S; Berends AMA; Fliedner S; Robledo M; Lenders JWM; Pacak K; Eisenhofer G; Pamporaki C
J Clin Endocrinol Metab; 2023 Jan; 108(2):397-404. PubMed ID: 36190922
[TBL] [Abstract][Full Text] [Related]
13. Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas.
Zhao L; Zhang T; Meng X; Zhang Z; Zhou Y; Fan H; Liu Y; Zhou X; Zhu H
Ann Med; 2023 Dec; 55(1):2203945. PubMed ID: 37129505
[TBL] [Abstract][Full Text] [Related]
14. Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas.
Meijs AC; Snel M; Corssmit EPM
Hormones (Athens); 2021 Jun; 20(2):395-403. PubMed ID: 33575936
[TBL] [Abstract][Full Text] [Related]
15. Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature.
Bancos I; Atkinson E; Eng C; Young WF; Neumann HPH;
Lancet Diabetes Endocrinol; 2021 Jan; 9(1):13-21. PubMed ID: 33248478
[TBL] [Abstract][Full Text] [Related]
16. Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review.
Wang X; Zhao Y; Liao Z; Zhang Y
Front Endocrinol (Lausanne); 2023; 14():1129622. PubMed ID: 37152961
[TBL] [Abstract][Full Text] [Related]
17. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.
Park H; Kim MS; Lee J; Kim JH; Jeong BC; Lee S; Lee SK; Cho SY; Jin DK
Front Endocrinol (Lausanne); 2020; 11():610746. PubMed ID: 33584544
[TBL] [Abstract][Full Text] [Related]
18. Catecholamine-induced cardiomyopathy: an endocrinologist's perspective.
Kumar A; Pappachan JM; Fernandez CJ
Rev Cardiovasc Med; 2021 Dec; 22(4):1215-1228. PubMed ID: 34957765
[TBL] [Abstract][Full Text] [Related]
19. Left Ventricular Structural and Functional Alterations in Patients With Pheochromocytoma/Paraganglioma Before and After Surgery.
Dobrowolski P; Januszewicz A; Klisiewicz A; Gosk-Przybyłek M; Pęczkowska M; Kabat M; Kwapiszewska A; Warchoł-Celińska E; Ambroziak U; Doroszko A; Toutounchi S; Gałązka Z; Bednarczuk T; Górnicka B; Januszewicz M; Hoffman P; Lenders JWM; Eisenhofer G; Prejbisz A
JACC Cardiovasc Imaging; 2020 Dec; 13(12):2498-2509. PubMed ID: 32950457
[TBL] [Abstract][Full Text] [Related]
20. Impact of body composition and genotype on haemodynamics during surgery for pheochromocytoma and paraganglioma.
Pang Y; Li M; Jiang J; Chen X; Fu Y; Wang C; He Y; Zhao Y; Wang Y; Guan X; Zhang L; Xu X; Gan Y; Liu Y; Xie Y; Tang T; Wang J; Xie B; Liang Z; Chen D; Liu H; Chen C; Eisenhofer G; Liu L; Yi X; Chen BT
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2843-2853. PubMed ID: 36068986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
